-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Calcium trinatrium diethylenetriaminepentaacetic acid hydrate
Category | Cytomegalovirus (CMV) |
CAS | 207226-35-5 |
Description | Calcium trinatrium diethylenetriaminepentaacetic acid hydrate is a metal chelator and useful antidote (such as acute cadmium intoxication), as well as a non-toxic CMV replication inhibitor. |
Product Information
Synonyms | Ca-DTPA trisodium salt hydrate; Diethylenetriamine-pentaacetic Acid Calcium Trisodium Salt hydrate; Calcium sodium 2,2',2'',2''',2''''-(1,2-ethanediylnitrilo)pentaacetate hydrate (1:3:1:x) |
Molecular Weight | 497.35 (anhydrous) |
Molecular Formula | C14H18CaN3Na3O10.xH2O |
Canonical SMILES | C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Na+].[Na+].[Na+].[Ca+2] |
InChI | InChI=1S/C14H23N3O10.Ca.3Na.H2O/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;;;;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);;;;;1H2/q;+2;3*+1;/p-5 |
InChIKey | AWBWYUNJDQLQGT-UHFFFAOYSA-I |
Melting Point | >281°C (dec.) |
Purity | ≥95% |
Solubility | Soluble in DMSO (Slightly), Methanol (Slightly) |
Appearance | White Solid |
Storage | Store at RT |
In Vitro | The antiviral activity of Calcium trinatrium diethylenetriaminepentaacetic acid hydrate is suppressed by metal ions with a decreasing potency order of Mn2+/Zn2+>Fe2+>Cu2+>Fe3+. Diethylenetriaminepentaacetic acid calcium trisodium salt hydrate inhibits CMV L-antigen production with EC50 ranging from 6.1 to 9.9 μM. |
PSA | 219.60000 |
Target | CMV |